U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock
83.96 USD
+2.48 (+3.04%)
83.96 USD
0 (0%)
Overall USPH gets a fundamental rating of 5 out of 10. We evaluated USPH against 101 industry peers in the Health Care Providers & Services industry. USPH has an average financial health and profitability rating. While showing a medium growth rate, USPH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
USPH had positive earnings in the past year.
In the past year USPH had a positive cash flow from operations.
Each year in the past 5 years USPH has been profitable.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of USPH (3.01%) is better than 64.36% of its industry peers.
Looking at the Return On Equity, with a value of 7.15%, USPH is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.11%, USPH is in the better half of the industry, outperforming 62.38% of the companies in the same industry.
USPH had an Average Return On Invested Capital over the past 3 years of 5.78%. This is below the industry average of 9.21%.
The last Return On Invested Capital (6.11%) for USPH is above the 3 year average (5.78%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROIC | 6.11% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
The Profit Margin of USPH (4.75%) is better than 79.21% of its industry peers.
USPH's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 11.52%, USPH belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
USPH's Operating Margin has declined in the last couple of years.
USPH's Gross Margin of 18.80% is on the low side compared to the rest of the industry. USPH is outperformed by 62.38% of its industry peers.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so USPH is destroying value.
The number of shares outstanding for USPH has been increased compared to 1 year ago.
The number of shares outstanding for USPH has been increased compared to 5 years ago.
The debt/assets ratio for USPH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.28 indicates that USPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of USPH (2.28) is comparable to the rest of the industry.
The Debt to FCF ratio of USPH is 2.82, which is a good value as it means it would take USPH, 2.82 years of fcf income to pay off all of its debts.
USPH has a better Debt to FCF ratio (2.82) than 74.26% of its industry peers.
USPH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, USPH is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.69
WACC8.79%
2.3 Liquidity
USPH has a Current Ratio of 1.20. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH has a Current ratio (1.20) which is comparable to the rest of the industry.
A Quick Ratio of 1.20 indicates that USPH should not have too much problems paying its short term obligations.
USPH has a Quick ratio (1.20) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.17% over the past year.
USPH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.76% yearly.
Looking at the last year, USPH shows a quite strong growth in Revenue. The Revenue has grown by 17.50% in the last year.
The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
3.2 Future
USPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.49% yearly.
USPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.56% yearly.
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 32.29, the valuation of USPH can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of USPH is on the same level as its industry peers.
When comparing the Price/Earnings ratio of USPH to the average of the S&P500 Index (27.19), we can say USPH is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 27.56, the valuation of USPH can be described as expensive.
USPH's Price/Forward Earnings ratio is in line with the industry average.
USPH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.29 | ||
| Fwd PE | 27.56 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, USPH is valued a bit cheaper than the industry average as 64.36% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, USPH is valued a bit cheaper than 64.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.43 | ||
| EV/EBITDA | 12.68 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USPH does not grow enough to justify the current Price/Earnings ratio.
USPH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.4
PEG (5Y)N/A
EPS Next 2Y8.66%
EPS Next 3Y8.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.21%, USPH has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.59, USPH pays a better dividend. On top of this USPH pays more dividend than 94.06% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.90, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.21% |
5.2 History
On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
75.41% of the earnings are spent on dividend by USPH. This is not a sustainable payout ratio.
USPH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP75.41%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
83.96
+2.48 (+3.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners107.98%
Inst Owner Change0%
Ins Owners1.87%
Ins Owner Change-1.06%
Market Cap1.28B
Revenue(TTM)758.71M
Net Income(TTM)36.02M
Analysts84.62
Price Target105.67 (25.86%)
Short Float %5.13%
Short Ratio4.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.21% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP75.41%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.82%
Min EPS beat(2)-3.42%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.36%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.56%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)2.04%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.02%
PT rev (1m)-1.49%
PT rev (3m)-2.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.29 | ||
| Fwd PE | 27.56 | ||
| P/S | 1.68 | ||
| P/FCF | 22.43 | ||
| P/OCF | 18.35 | ||
| P/B | 2.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.68 |
EPS(TTM)2.6
EY3.1%
EPS(NY)3.05
Fwd EY3.63%
FCF(TTM)3.74
FCFY4.46%
OCF(TTM)4.57
OCFY5.45%
SpS49.92
BVpS33.13
TBVpS-23.9
PEG (NY)8.4
PEG (5Y)N/A
Graham Number44.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROCE | 8.08% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.29% | ||
| ROICexgc | 36.03% | ||
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% | ||
| FCFM | 7.5% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 1.37 | ||
| Cap/Depr | 53.9% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | 9.84 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 157.98% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 2.28 |
F-Score6
WACC8.79%
ROIC/WACC0.69
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.26%
EBIT Next 3Y18.33%
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-4.01%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%
U.S. PHYSICAL THERAPY INC / USPH FAQ
What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?
ChartMill assigns a fundamental rating of 5 / 10 to USPH.
What is the valuation status for USPH stock?
ChartMill assigns a valuation rating of 3 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Overvalued.
What is the profitability of USPH stock?
U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 6 / 10.
What are the PE and PB ratios of U.S. PHYSICAL THERAPY INC (USPH) stock?
The Price/Earnings (PE) ratio for U.S. PHYSICAL THERAPY INC (USPH) is 32.29 and the Price/Book (PB) ratio is 2.53.
Is the dividend of U.S. PHYSICAL THERAPY INC sustainable?
The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 75.41%.